mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |